New pill shows promise for leukemia patients out of options
Disease control
Recruiting now
This early-stage trial tests an experimental pill called MRX-2843 in teens and adults whose acute leukemia has returned or not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. About 50 participants will take the pill daily in 2…
Phase: PHASE1 • Sponsor: Meryx, Inc. • Aim: Disease control
Last updated May 05, 2026 11:53 UTC